156 related articles for article (PubMed ID: 16100295)
1. Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers.
Hebert MF; Blough DK; Townsend RW; Allison M; Buell D; Keirns J; Bekersky I
J Clin Pharmacol; 2005 Sep; 45(9):1018-24. PubMed ID: 16100295
[TBL] [Abstract][Full Text] [Related]
2. Concomitant cyclosporine and micafungin pharmacokinetics in healthy volunteers.
Hebert MF; Townsend RW; Austin S; Balan G; Blough DK; Buell D; Keirns J; Bekersky I
J Clin Pharmacol; 2005 Aug; 45(8):954-60. PubMed ID: 16027407
[TBL] [Abstract][Full Text] [Related]
3. Steady-state pharmacokinetics of micafungin and voriconazole after separate and concomitant dosing in healthy adults.
Keirns J; Sawamoto T; Holum M; Buell D; Wisemandle W; Alak A
Antimicrob Agents Chemother; 2007 Feb; 51(2):787-90. PubMed ID: 17116670
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunction.
Hebert MF; Smith HE; Marbury TC; Swan SK; Smith WB; Townsend RW; Buell D; Keirns J; Bekersky I
J Clin Pharmacol; 2005 Oct; 45(10):1145-52. PubMed ID: 16172179
[TBL] [Abstract][Full Text] [Related]
5. Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits.
Groll AH; Mickiene D; Petraitis V; Petraitiene R; Ibrahim KH; Piscitelli SC; Bekersky I; Walsh TJ
Antimicrob Agents Chemother; 2001 Dec; 45(12):3322-7. PubMed ID: 11709303
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants.
Heresi GP; Gerstmann DR; Reed MD; van den Anker JN; Blumer JL; Kovanda L; Keirns JJ; Buell DN; Kearns GL
Pediatr Infect Dis J; 2006 Dec; 25(12):1110-5. PubMed ID: 17133155
[TBL] [Abstract][Full Text] [Related]
7. Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers.
Hebert MF; Park JM; Chen YL; Akhtar S; Larson AM
J Clin Pharmacol; 2004 Jan; 44(1):89-94. PubMed ID: 14681346
[TBL] [Abstract][Full Text] [Related]
8. Optimal prophylactic dosage and disposition of micafungin in living donor liver recipients.
Kishino S; Ohno K; Shimamura T; Furukawatodo H
Clin Transplant; 2004 Dec; 18(6):676-80. PubMed ID: 15516243
[TBL] [Abstract][Full Text] [Related]
9. Micafungin: a new echinocandin antifungal.
Joseph JM; Jain R; Danziger LH
Pharmacotherapy; 2007 Jan; 27(1):53-67. PubMed ID: 17192162
[TBL] [Abstract][Full Text] [Related]
10. Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.
Dowell JA; Stogniew M; Krause D; Henkel T; Damle B
J Clin Pharmacol; 2007 Mar; 47(3):305-14. PubMed ID: 17322142
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant.
Hiemenz J; Cagnoni P; Simpson D; Devine S; Chao N; Keirns J; Lau W; Facklam D; Buell D
Antimicrob Agents Chemother; 2005 Apr; 49(4):1331-6. PubMed ID: 15793107
[TBL] [Abstract][Full Text] [Related]
12. Once-weekly micafungin therapy is as effective as daily therapy for disseminated candidiasis in mice with persistent neutropenia.
Gumbo T; Drusano GL; Liu W; Kulawy RW; Fregeau C; Hsu V; Louie A
Antimicrob Agents Chemother; 2007 Mar; 51(3):968-74. PubMed ID: 17194830
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of oesophageal candidiasis by micafungin: a novel systemic antifungal agent.
Pettengell K; Mynhardt J; Kluyts T; Lau W; Facklam D; Buell D;
Aliment Pharmacol Ther; 2004 Aug; 20(4):475-81. PubMed ID: 15298643
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of micafungin in transplantation recipients.
Forrest GN; Rasetto F; Akpek G; Philosophe B
Transplantation; 2006 Dec; 82(11):1549. PubMed ID: 17164733
[No Abstract] [Full Text] [Related]
15. Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients.
Leather H; Boyette RM; Tian L; Wingard JR
Biol Blood Marrow Transplant; 2006 Mar; 12(3):325-34. PubMed ID: 16503502
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
[TBL] [Abstract][Full Text] [Related]
17. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
Pappas PG; Rotstein CM; Betts RF; Nucci M; Talwar D; De Waele JJ; Vazquez JA; Dupont BF; Horn DL; Ostrosky-Zeichner L; Reboli AC; Suh B; Digumarti R; Wu C; Kovanda LL; Arnold LJ; Buell DN
Clin Infect Dis; 2007 Oct; 45(7):883-93. PubMed ID: 17806055
[TBL] [Abstract][Full Text] [Related]
18. Micafungin does not influence the concentration of tacrolimus in patients after allogeneic hematopoietic stem cell transplantation.
Fukuoka N; Imataki O; Ohnishi H; Kitanaka A; Kubota Y; Ishida T; Tanaka T
Transplant Proc; 2010 Sep; 42(7):2725-30. PubMed ID: 20832577
[TBL] [Abstract][Full Text] [Related]
19. Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor.
Brandhorst G; Tenderich G; Zittermann A; Oezpeker C; Koerfer R; Oellerich M; Armstrong VW
Ther Drug Monit; 2008 Feb; 30(1):113-6. PubMed ID: 18223473
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics-pharmacodynamics of micafungin in Japanese patients with deep-seated mycosis.
Tabata K; Katashima M; Kawamura A; Kagayama A; Kohno S
Eur J Drug Metab Pharmacokinet; 2006; 31(2):123-8. PubMed ID: 16898081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
